SMAD2 and pulmonary fibrosis: Recent studies from our group have found that inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/Smad2 loop [23], and lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a [24].